VINC Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (26 Apr 2024 @ 16:00):

Vincerx Pharma, Inc., a clinical-stage biopharmaceutical company, researches and develops therapies to address unmet medical needs for the treatment of cancer in the United States...

Stats
Today's Volume	1.72M
Average Volume	1.18M
Market Cap	15.63M
EPS	$0 ( 2024-03-26 )
Next earnings date	( $-0.260 ) 2024-05-09
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.390
ATR14	$0.0120 (1.65%)

Insider Trading

Date	Person	Action	Amount	type
2024-03-07	Izumi Raquel E.	Buy	123 750	Stock Option (right to buy)
2024-03-07	Seelenberger Alexander A.	Buy	93 750	Stock Option (right to buy)
2024-03-07	Hamdy Ahmed Md	Buy	146 746	Stock Option (right to buy)
2024-03-07	Thomas Tom C	Buy	93 750	Stock Option (right to buy)
2023-08-11	Seelenberger Alexander A.	Buy	10 500	Common Stock

INSIDER POWER
100.00
Last 97 transactions
Buy: 7 261 732 \| Sell: 1 766 942

Volume Correlation

Long: -0.44 (neutral)

Short: -0.91 (very strong negative)

Signal:(31.431) Neutral

Vincerx Pharma, Inc. Correlation

10 Most Positive Correlations
SVAC	0.929
PAIC	0.909
RMRM	0.901
TLGT	0.894
MTSL	0.893
SVOK	0.862
MODV	0.861
CLMT	0.858
BOXL	0.842
ABNB	0.839

10 Most Negative Correlations
AMRB	-0.955
NETE	-0.938
MMAC	-0.917
RAVN	-0.869
SRAC	-0.86
SBBP	-0.859
LWAC	-0.855
MGPI	-0.841
BOCH	-0.836
SHSP	-0.808

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Vincerx Pharma, Inc. Correlation - Currency/Commodity

-0.72
( moderate negative )

-0.77
( moderate negative )

0.00
( neutral )

0.16
( neutral )

Vincerx Pharma, Inc. Financials

Annual	2023
Revenue:	$0
Gross Profit:	$-915 000 (0.00 %)
EPS:	$-1.890

FY	2023
Revenue:	$0
Gross Profit:	$-915 000 (0.00 %)
EPS:	$-1.890

FY	2022
Revenue:	$0
Gross Profit:	$-939 000 (0.00 %)
EPS:	$-2.72

FY	2021
Revenue:	$0.00
Gross Profit:	$0.00 (0.00 %)
EPS:	$-7.48

Financial Reports:

No articles found.

Vincerx Pharma, Inc.

Vincerx Pharma, Inc., a clinical-stage biopharmaceutical company, researches and develops therapies to address unmet medical needs for the treatment of cancer in the United States. Its lead product candidate is VIP152, a cyclin-dependent kinase-9 inhibitor for treating patients with advanced cancer. The company's preclinical stage product candidates include VIP217, an oral PTEFb/CDK9 inhibitor; VIP236, a small molecule drug conjugate to treat solid tumors; and VIP943 and VIP924 for the treatment of hematologic malignancies. Vincerx Pharma, Inc. was founded in 2019 is headquartered in Palo Alto, California.